Abstract
Obesity is now a widespread disorder, and its prevalence has become a critical concern worldwide, due to its association with common co-morbidities like cancer, cardiovascular diseases and diabetes. Adipose tissue is an endocrine organ and therefore plays a critical role in the survival of an individual, but its dysfunction or excess is directly linked to obesity. The journey from multipotent mesenchymal stem cells to the formation of mature adipocytes is a well-orchestrated program which requires the expression of several genes, their transcriptional factors, and signaling intermediates from numerous pathways. Understanding all the intricacies of adipogenesis is vital if we are to counter the current epidemic of obesity because the limited understanding of these intricacies is the main barrier to the development of potent therapeutic strategies against obesity. In particular, AMP-Activated Protein Kinase (AMPK) plays a crucial role in regulating adipogenesis – it is arguably the central cellular energy regulation protein of the body. Since AMPK promotes the development of brown adipose tissue over that of white adipose tissue, special attention has been given to its role in adipose tissue development in recent years. In this review, we describe the molecular mechanisms involved in adipogenesis, the role of signaling pathways and the substantial role of activated AMPK in the inhibition of adiposity, concluding with observations which will support the development of novel chemotherapies against obesity epidemics.
Highlights
Obesity is an increasingly prevalent disorder around the globe promoted by genetic, nutritional, and environmental factors
We describe the molecular mechanisms involved in adipogenesis, the role of signaling pathways and the substantial role of activated AMPK in the inhibition of adiposity, concluding with observations which will support the development of novel chemotherapies against obesity epidemics
This review aims to provide a comprehensive knowledge of the key molecular factors involved in adipocyte differentiation, and the antiadipogenic role of AMPK and its mechanism of activation in adipose tissue
Summary
Obesity is an increasingly prevalent disorder around the globe promoted by genetic, nutritional, and environmental factors. Obesity is a multifactorial chronic disease, linked to other disorders including cancer, insulin resistance, cardiovascular diseases and type-2 diabetes (Cohen et al, 2014; Tung et al, 2017; Ghaben and Scherer, 2019). According to World Health Organization (WHO), in 2016, more than 1.9 billion adults were overweight, of whom 650 million were suffereing from obesity, with approximately 2.8 million adults dying each year due Molecular Opportunities in Adipogenesis Intervention to the condition (World Health Organization, 2020). The epidemic of obesity has focused researchers’ attention on understanding the development of adipose tissue and fat cells, regulated by a multistep process known as adipogenesis (Lefterova and Lazar, 2009). Improved and holistic knowledge of the processes governing adipogenesis is required if we are to counter the burgeoning epidemic (Rosen and MacDougald, 2006)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.